Overview
The primary objective of this study is to evaluate the ability of TOME to increase Medication for Opioid Use Disorder (MOUD) and opioid-overdose knowledge in pregnant and postpartum persons.
Description
This is an intent-to-treat, two-arm, open-label, randomized controlled trial. Eligible participants will be randomized in a 1:1 ratio to TOME or Control, balancing on site. Participants will receive the assigned intervention following randomization and will complete a three week follow-up assessment.
Eligibility
Inclusion Criteria:
Potential participants must be:
- 18 years of age or older;
- Pregnant or be within 12 months postpartum;
- Enrolled in MOUD (either buprenorphine or methadone) at the study site or affiliated clinic where enrollment can be confirmed;
- Able to understand the study, and having understood, provide written informed consent in English
Exclusion Criteria:
Potential participants must not:
- have suicidal or homicidal ideation requiring immediate attention.